Clinical trialNCT00084435WithdrawnPhase 2Interventional

S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer

SponsorSWOG Cancer Research NetworkEnrollment0Head and Neck Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Cisplatin and docetaxel may make the tumor cells more sensitive to radiation therapy. Giving chemoradiotherapy after surgery may kill any remaining tumor cells. PURPOSE: This phase II trial is studying how well adjuvant chemoradiotherapy using cisplatin and docetaxel works in treating patients with completely resected stage III or stage IV head and neck cancer.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

George H. Yoo, MD
Barbara Ann Karmanos Cancer Institute
Study Chair
clinicaltrials.gov ↗
Harold E. Kim, MD
Barbara Ann Karmanos Cancer Institute
Study Chair
clinicaltrials.gov ↗
Prakash C. Neupane, MD
St. Mary's Cancer Specialists at St. Mary's Health Center
Principal Investigator
clinicaltrials.gov ↗
Stephen K. Williamson, MD
University of Kansas
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
Feist-Weiller Cancer Center at Louisiana State University Health Sciences
Shreveport, Louisiana, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
Saint Louis University Cancer Center
St Louis, Missouri, United States
Rutherford Hospital
Rutherfordton, North Carolina, United States
Adena Regional Medical Center
Chillicothe, Ohio, United States
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
Ccop - Columbus
Columbus, Ohio, United States
Doctors Hospital at Ohio Health
Columbus, Ohio, United States
Grant Riverside Cancer Services
Columbus, Ohio, United States
Mount Carmel Health - West Hospital
Columbus, Ohio, United States
Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
Grady Memorial Hospital
Delaware, Ohio, United States
Community Oncology Group at Cleveland Clinic Cancer Center
Independence, Ohio, United States
Fairfield Medical Center
Lancaster, Ohio, United States
Strecker Cancer Center at Marietta Memorial Hospital
Marietta, Ohio, United States
Licking Memorial Cancer Care Program at Licking Memorial Hospital
Newark, Ohio, United States
Community Hospital of Springfield and Clark County
Springfield, Ohio, United States
Mercy Medical Center
Springfield, Ohio, United States
Mount Carmel Cancer Services at Mount Carmel St. Ann'S Hospital
Westerville, Ohio, United States
Cleveland Clinic - Wooster
Wooster, Ohio, United States
Genesis - Good Samaritan Hospital
Zanesville, Ohio, United States
Anmed Health Cancer Center
Anderson, South Carolina, United States
Ccop - Upstate Carolina
Spartanburg, South Carolina, United States
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cisplatin →Docetaxel →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2005
Primary completion: 31 Jan 2007
Completion: 31 Jan 2007
Last update posted: 14 Jun 2012
Registered enrollment: 0
Registry id: NCT00084435

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.